Comments
Biocon shares gained as much as 2.4 per cent in morning trade.
At 11.15 am, the shares were trading off morning highs at Rs 473.90, up 1.07 per cent or Rs 5.
The company has got approval for insulin Glargine, used to control blood sugar, from Mexican health authority.
The market size of this drug in Mexico is about $40 million, according to analysts. We expect approval for the drug in other geographies, too, they added.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.